Patient Sample Collection for a Next-Generation, Off-The-Shelf CAR-iNKT Cell Therapy for Multiple Myeloma and collection of cell lines (HEK239T, HT-29, MM.1S from ATCC) and human Cord Blood (CD 34+ HSCs from HemaCare) from commercial sources

This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.

• If you need assistance with ClinicalTrials.gov registration for an oncology study, please contact the Jonsson Comprehensive Cancer Center's Office of Regulatory Compliance.
• If you need assistance with ClinicalTrials.gov registration for a non-oncology study, please contact the Office of Regulatory Affairs.